Loading clinical trials...
Loading clinical trials...
A Phase II Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration
Conditions
Interventions
Fenretinide
Start Date
December 1, 2006
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2010
Last Updated
June 22, 2010
NCT06779773
NCT06990269
NCT06970665
NCT07160179
NCT06557460
NCT05949593
Lead Sponsor
Sirion Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions